Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02791555 · ClinicalTrials.gov registry record

Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

A clinical trial, sponsored by UConn Health.

Terminated
Registry status
2
Enrollment target

NCT02791555: Clinical Trial study, sponsored by UConn Health.

NCT02791555 is a clinical trial that was terminated before completion, run by UConn Health. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02791555 was terminated before completion, sponsored by UConn Health.

TERMINATED
Registry status
2 participants
Enrollment target

Study Summary

The investigators are evaluating the effect of Pradaxa in comparison to warfarin on bone turnover and bone density in men and women with atrial fibrillation.

Primary Outcome

Measurement of bone density using DXA

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2016-06
Est. Completion 2017-03
UConn Health

178 total trials

Why NCT02791555 stopped before completion

NCT02791555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02791555 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02791555 about?

NCT02791555 is a clinical study titled "Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers". The investigators are evaluating the effect of Pradaxa in comparison to warfarin on bone turnover and bone density in men and women with atrial fibrillation.

What is the current status of trial NCT02791555?

This trial is currently terminated. The enrollment target is 2 participants. The study started on 2016-06. Estimated completion is 2017-03.

Who is sponsoring clinical trial NCT02791555?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02791555, the US trial registry maintained by the National Library of Medicine. NCT02791555 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.